American Well PE Ratio 2019-2025 | AMWL

Current and historical p/e ratio for American Well (AMWL) from 2019 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. American Well PE ratio as of June 09, 2025 is 0.00.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

American Well PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2025-06-10 7.37 0.00
2025-03-31 7.88 $-10.19 0.00
2024-12-31 7.25 $-14.00 0.00
2024-09-30 9.48 $-14.63 0.00
2024-06-30 6.50 $-21.36 0.00
2024-03-31 16.22 $-24.60 0.00
2023-12-31 29.80 $-48.00 0.00
2023-09-30 23.40 $-49.00 0.00
2023-06-30 42.00 $-44.40 0.00
2023-03-31 47.20 $-42.80 0.00
2022-12-31 56.60 $-19.60 0.00
2022-09-30 71.80 $-18.80 0.00
2022-06-30 86.40 $-17.80 0.00
2022-03-31 84.20 $-15.80 0.00
2021-12-31 120.80 $-13.80 0.00
2021-09-30 182.20 $-10.20 0.00
2021-06-30 251.60 $-24.60 0.00
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.111B $0.254B
American Well Corp provides telehealth platform principally in the United States and globally. American Well Corp is based in BOSTON.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $46.097B 58.90
Hims & Hers Health (HIMS) United States $12.727B 132.23
Tempus AI (TEM) United States $11.588B 0.00
IRhythm Technologies (IRTC) United States $4.708B 0.00
Inspire Medical Systems (INSP) United States $4.030B 62.97
Hinge Health (HNGE) United States $2.965B 0.00
Privia Health (PRVA) United States $2.833B 193.67
Enovis (ENOV) United States $1.879B 10.48
Schrodinger (SDGR) United States $1.869B 0.00
Phreesia (PHR) United States $1.636B 0.00
Clover Health Investments (CLOV) United States $1.517B 0.00
Omnicell (OMCL) United States $1.484B 26.18
Azenta (AZTA) United States $1.340B 62.30
10x Genomics (TXG) United States $1.242B 0.00
Fulgent Genetics (FLGT) United States $0.664B 0.00
Claritev (CTEV) United States $0.633B 0.00
Butterfly Network (BFLY) United States $0.613B 0.00
Talkspace (TALK) United States $0.549B 164.00
Veradigm (MDRX) United States $0.476B 0.00
Standard BioTools (LAB) United States $0.410B 0.00
Outset Medical (OM) United States $0.376B 0.00
TruBridge (TBRG) United States $0.363B 805.67
Health Catalyst (HCAT) United States $0.290B 0.00
Nyxoah SA (NYXH) Belgium $0.264B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.191B 0.00
KORU Medical Systems (KRMD) United States $0.139B 0.00
Pulmonx (LUNG) United States $0.137B 0.00
EUDA Health Holdings (EUDA) Singapore $0.125B 0.00
MDxHealth SA (MDXH) Belgium $0.103B 0.00
CareCloud (CCLD) United States $0.092B 3.52
111 (YI) China $0.072B 0.00
HeartBeam (BEAT) United States $0.054B 0.00
P3 Health Partners (PIII) United States $0.047B 0.00
Zepp Health (ZEPP) Netherlands $0.035B 0.00
Zhongchao (ZCMD) China $0.031B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.031B 0.00
Streamline Health Solutions (STRM) United States $0.022B 0.00
Precipio (PRPO) United States $0.018B 0.00
Bullfrog AI Holdings (BFRG) United States $0.016B 0.00
MSP Recovery (MSPR) United States $0.012B 0.00
Strata Skin Sciences (SSKN) United States $0.010B 0.00
Predictive Oncology (POAI) United States $0.008B 0.00
Movano (MOVE) United States $0.005B 0.00
Evaxion - (EVAX) Denmark $0.004B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.003B 0.00
Healthcare Triangle (HCTI) United States $0.000B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00